| No |
variable |
Surname |
Belongs to |
OBDS/module |
Cardinality |
Optional |
Value range |
agreement
|
| 1 |
Gender |
|
person |
3.9 |
1 |
n |
|
|
| 2 |
birth date |
|
person |
3.10 |
1 |
n |
moon |
|
| 3 |
Died (vital status) |
|
person |
new |
1 |
n |
Died yes/no |
#Vitalstatus
|
| 4 |
Date vital status |
|
person |
new |
1 |
n |
moon |
|
| 5 |
The cause of death (official basic disorders) n. ICD code |
|
person |
20.3 |
1 |
J |
|
#TODESULE
|
| 6 |
The cause of death (official basic disorders) n. ICD edition |
|
person |
20.4 |
1 |
J |
|
|
| 7 |
Further causes of death n. ICD code |
|
person |
new |
n |
J |
|
|
| 8th |
Further causes of death n. ICD version |
|
person |
new |
n |
J |
|
|
| 9 |
Diagnostic datum |
|
Primary diagnosis |
5.6 |
1 |
n |
moon |
|
| 10 |
Place of residence (district) b. diagnosis |
|
Primary diagnosis |
3.15 |
1 |
n |
District index (5 digits) |
|
| 11 |
Diagnosis according to ICD code |
|
Primary diagnosis |
5.1 |
1 |
n |
four -digit |
|
| 12 |
Diagnosis according to ICD version |
|
Primary diagnosis |
5.2 |
1 |
n |
|
|
| 13 |
Localization (ICD-O) code |
|
Primary diagnosis |
5.4 |
1 |
n |
|
|
| 14 |
Localization (ICD-O) version |
|
Primary diagnosis |
5.5 |
1 |
J |
|
|
| 15 |
Morphology (ICD-O) code |
|
Primary diagnosis |
6.3 |
1 |
n |
|
#Morphology [InlineCard]
|
| 16 |
Morphology (ICD-O) version (or Blue Book) |
|
Primary diagnosis |
6.4 |
1 |
J |
|
|
| 17 |
Grading |
|
Primary diagnosis |
6.6 |
1 |
J |
|
|
| 18 |
Number of lymph nodes examined |
|
Primary diagnosis |
6.7 |
1 |
J |
|
|
| 19 |
Number of affected lymph nodes |
|
Primary diagnosis |
6.8 |
1 |
J |
|
|
| 20 |
CTNM version |
|
Primary diagnosis |
8.2 |
1 |
J |
|
#Tnm- [inlineCard]
|
| 21 |
CTNM-Y symbol |
|
Primary diagnosis |
8.3 |
1 |
J |
|
|
| 22 |
CTNM-R-icon |
|
Primary diagnosis |
8.4 |
1 |
J |
|
|
| 23 |
CTNM-A symbol |
|
Primary diagnosis |
8.5 |
1 |
J |
|
|
| 24 |
CTNM-T |
|
Primary diagnosis |
8.9 |
1 |
J |
|
|
| 25 |
CTNM-N |
|
Primary diagnosis |
8.11 |
1 |
J |
|
|
| 26 |
CTNM-M |
|
Primary diagnosis |
8.12 |
1 |
J |
|
|
| 27 |
CTNM-prefix t |
|
Primary diagnosis |
8.6 |
1 |
J |
|
|
| 28 |
CTNM-Prefix-N |
|
Primary diagnosis |
8.7 |
1 |
J |
|
|
| 29 |
CTNM-Prefix-M |
|
Primary diagnosis |
8.8 |
1 |
J |
|
|
| 30 |
CTNM: M symbol |
|
Primary diagnosis |
8.10 |
1 |
J |
|
|
| 31 |
CTNM: L-category |
|
Primary diagnosis |
8.13 |
1 |
J |
|
|
| 32 |
CTNM: V-category |
|
Primary diagnosis |
8.14 |
1 |
J |
|
|
| 33 |
CTNM: PN category |
|
Primary diagnosis |
8.15 |
1 |
J |
|
|
| 34 |
CTNM: S category |
|
Primary diagnosis |
8.16 |
1 |
J |
|
|
| 35 |
C-TNM-Uicc |
|
Primary diagnosis |
8.17 |
1 |
J |
|
|
| 36 |
PTNM version |
|
Primary diagnosis |
8.2 |
1 |
J |
|
|
| 37 |
Ptnm-Y symbol |
|
Primary diagnosis |
8.3 |
1 |
J |
|
|
| 38 |
PTNM-R-icon |
|
Primary diagnosis |
8.4 |
1 |
J |
|
|
| 39 |
PTNM-A symbol |
|
Primary diagnosis |
8.5 |
1 |
J |
|
|
| 40 |
PTNM-T |
|
Primary diagnosis |
8.9 |
1 |
J |
|
|
| 41 |
Ptnm-n |
|
Primary diagnosis |
8.11 |
1 |
J |
|
|
| 42 |
PTNM-M |
|
Primary diagnosis |
8.12 |
1 |
J |
|
|
| 43 |
PTNM-Prefix-T |
|
Primary diagnosis |
8.6 |
1 |
J |
|
|
| 44 |
Ptnm-Prefix-N |
|
Primary diagnosis |
8.7 |
1 |
J |
|
|
| 45 |
PTNM-Prefix-M |
|
Primary diagnosis |
8.8 |
1 |
J |
|
|
| 46 |
PTNM: M symbol |
|
Primary diagnosis |
8.10 |
1 |
J |
|
|
| 47 |
PTNM: L-category |
|
Primary diagnosis |
8.13 |
1 |
J |
|
|
| 48 |
PTNM: V-category |
|
Primary diagnosis |
8.14 |
1 |
J |
|
|
| 49 |
PTNM: PN category |
|
Primary diagnosis |
8.15 |
1 |
J |
|
|
| 50 |
PTNM: S category |
|
Primary diagnosis |
8.16 |
1 |
J |
|
|
| 51 |
ptnm-uicc |
|
Primary diagnosis |
8.17 |
1 |
J |
|
#Uicc- [inlineCard]
|
| 52 |
Mestastases seat |
|
Primary diagnosis |
11.1 |
n |
J |
|
#Seat-the remote metastasis- (Age-primary diagnostic diagnosis [inlinecard])
|
| 53 |
Further classification: name |
|
Primary diagnosis |
9.2 |
n |
J |
|
|
| 54 |
Further classification: stage (expression) |
|
Primary diagnosis |
9.3 |
n |
J |
|
|
| 55 |
Diagnostic protection |
|
Primary diagnosis |
5.7 |
1 |
n |
Like OBDS, additionally DCO and unknown |
#Diagnosis protection
|
| 56 |
Side locals in paired organs |
|
Primary diagnosis |
5.8 |
1 |
J |
|
|
| 57 |
Dcn |
|
Primary diagnosis |
new |
1 |
n |
Yes No |
#DCN- (Death Certificate Notified)
|
| 58 |
Survival time (distance diagnostic death) |
|
Primary diagnosis |
new |
|
J |
Number of days |
|
| 59 |
Tumor size in mm (invasive) |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 60 |
Tumor size in mm (DCIS) |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 61 |
Prate therapeutic menopause status |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 62 |
Hormone receptor status :: estrogen |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 63 |
Hormone receptor status: progesterone |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 64 |
Her2neu status |
|
Primary diagnosis |
Chest module |
1 |
J |
|
|
| 65 |
PSA value |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 66 |
Date PSA |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 67 |
Gleason score primary value |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 68 |
Gleason score of secondary value |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 69 |
Gleason score overall score |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 70 |
Gleason score occasion |
|
Primary diagnosis |
Prostate module |
1 |
J |
|
|
| 71 |
Tumor thickness in mm |
|
Primary diagnosis |
Melanoma module |
1 |
J |
|
|
| 72 |
Ulceration |
|
Primary diagnosis |
Melanoma module |
1 |
J |
|
|
| 73 |
LDH |
|
Primary diagnosis |
Melanoma module |
1 |
J |
|
|
| 74 |
Rectum: distance of the tumor underride to the anocutan line |
|
Primary diagnosis |
Module Darm |
1 |
J |
|
|
| 75 |
Mutation K-ras-Onkogen |
|
Primary diagnosis |
Module Darm |
1 |
J |
|
|
| 76 |
Operating date |
|
surgery |
13.2 |
1 |
n |
|
|
| 77 |
Type of operation according to OPS code |
|
surgery |
13.3 |
n |
n |
Ops |
|
| 78 |
Type of operation according to OPS version |
|
surgery |
13.4 |
1 |
n |
|
|
| 79 |
Intention of the operation |
|
surgery |
13.1 |
1 |
n |
|
|
| 80 |
Local assessment residual status |
|
surgery |
10.1 |
1 |
J |
|
#Total assessment residual status (for-surgery [inlineCard])-not-transmitted
|
| 81 |
Distance primary diagnosis to surgery |
|
surgery |
recalculated) |
1 |
J |
Number of days |
|
| 82 |
Start radiation therapy |
|
radiotherapy |
14.5 |
1 |
n |
|
|
| 83 |
intention |
|
radiotherapy |
14.1 |
1 |
J |
|
|
| 84 |
Position for the operation |
|
radiotherapy |
14.2 |
1 |
J |
|
|
| 85 |
Application type |
|
radiotherapy |
14.7 |
1 |
J |
|
#Applications-unspoken-
|
| 86 |
Target area |
|
radiotherapy |
14.3 |
1 |
? |
|
|
| 87 |
Page target area |
|
radiotherapy |
14.4 |
1 |
? |
|
|
| 88 |
Duration of radiation therapy |
|
radiotherapy |
new (calculated from 14.5 and 14.6) |
1 |
J |
|
#Permanent ray therapy
|
| 89 |
Distance primary diagnosis until the beginning of radiation therapy |
|
radiotherapy |
recalculated) |
1 |
J |
|
|
| 90 |
Intention of systemic therapy |
|
Systemic therapy |
16.1 |
1 |
n |
|
|
| 91 |
Position systemic therapy for the operation |
|
Systemic therapy |
16.2 |
1 |
n |
|
|
| 92 |
Art d. Systemic therapy |
|
Systemic therapy |
16.3 |
1 |
n |
|
#Art-Systemische-Therapy- (Oder-Awartenden) therapy
|
| 93 |
substance |
|
Systemic therapy |
16.6 |
n |
J |
Description or ATC code |
#Building substance [InlineCard]
|
| 94 |
protocol |
|
Systemic therapy |
16.4 |
1 |
J |
|
#Settup protocol [inlineCard]
|
| 95 |
Start systemic therapy |
|
Systemic therapy |
16.5 |
1 |
n |
|
|
| 96 |
Duration of systemic therapy |
|
Systemic therapy |
recalculated) |
1 |
J |
|
|
| 97 |
Distance primary diagnosis until the beginning of systemic therapy |
|
Systemic therapy |
recalculated) |
1 |
J |
|
|
| 98 |
Date of follow -up event |
|
Consequence event |
17.1 |
1 |
n |
|
|
| 99 |
TNM version |
|
Consequence event |
8.2 |
1 |
J |
|
|
| 100 |
TNM-Y symbol |
|
Consequence event |
8.3 |
1 |
J |
|
|
| 101 |
TNM-R-icon |
|
Consequence event |
8.4 |
1 |
J |
|
|
| 102 |
TNM-A symbol |
|
Consequence event |
8.5 |
1 |
J |
|
|
| 103 |
TNM-T |
|
Consequence event |
8.9 |
1 |
J |
|
|
| 104 |
TNM-N |
|
Consequence event |
8.11 |
1 |
J |
|
|
| 105 |
TNM-M |
|
Consequence event |
8.12 |
1 |
J |
|
|
| 106 |
TNM-prefix t |
|
Consequence event |
8.6 |
1 |
J |
|
|
| 107 |
TNM Prefix-N |
|
Consequence event |
8.7 |
1 |
J |
|
|
| 108 |
TNM-Prefix-M |
|
Consequence event |
8.8 |
1 |
J |
|
|
| 109 |
TNM: M symbol |
|
Consequence event |
8.10 |
1 |
J |
|
|
| 110 |
TNM: L-category |
|
Consequence event |
8.13 |
1 |
J |
|
|
| 111 |
TNM: V-category |
|
Consequence event |
8.14 |
1 |
J |
|
|
| 112 |
TNM: PN category |
|
Consequence event |
8.15 |
1 |
J |
|
|
| 113 |
TNM: S category |
|
Consequence event |
8.16 |
1 |
J |
|
|
| 114 |
TNM-Uicc |
|
Consequence event |
8.17 |
1 |
J |
|
|
| 115 |
Further classification: name |
|
Consequence event |
9.2 |
1 |
J |
|
|
| 116 |
Further classification: stage (expression) |
|
Consequence event |
9.3 |
1 |
J |
|
|
| 117 |
Total settlement tumor status |
|
Consequence event |
17.2 |
1 |
n |
|
|
| 118 |
Course of local tumor status |
|
Consequence event |
17.3 |
1 |
J |
|
|
| 119 |
Course tumor status lymph nodes |
|
Consequence event |
17.4 |
1 |
J |
|
|
| 120 |
Course tumor status distant metastases |
|
Consequence event |
17.5 |
1 |
J |
|
|
| 121 |
Mestastases seat |
|
Consequence event |
11.1 |
n |
J
|